Osteoarthritis Injectable Market Size to Reach USD 15.15 Billion by 2034 at a 7.0% CAGR from 2026 to 2034
Osteoarthritis injectable industry size is estimated at USD 8.30 billion in 2025 and forecasted to reach USD 15.50 billion in 2034 with a CAGR of 7.0%. Osteoarthritis injections include intra-articular injection therapies aimed at alleviating pain, increasing mobility, and controlling osteoarthritis without resorting to surgery immediately.
Key Statistics:
- Market Size (2025): USD 8.30 Billion
- Market Size (2034): USD 15.15 Billion
- CAGR (2026-2034): 7.0%
- Dominating Region: North America
Report Highlights:
- The hyaluronic acid injections segment was dominant by 39.7% revenue share in 2025 due to strong demand for joint lubrication and pain relief.
- The hospital pharmacies segment dominated in 2025 with 48.5% revenue share due to strong physician-led treatment administration and higher patient volume.
- The PRP injections market is anticipated to show rapid at CAGR of 7.8% growth due to the increasing demand for regenerative joint therapy products.
- North America dominated the osteoarthritis injectable market by 51.74% market share due to strong healthcare spending and advanced orthopedic treatment access.
- Asia Pacific is the fastest-growing region in the osteoarthritis injectable market, growing at a CAGR of 7.7% due to rising elderly population and improving orthopedic care in China and India.
What’s Included in Osteoarthritis Injectable Report?
The report presents a detailed overview of the market for osteoarthritis injectable based on injectable type, anatomy, and end user. It includes regional analysis, demand trends, treatment adoption patterns, and competitive landscape.
What are Driving Factors and Emerging Trends of Osteoarthritis Injectable Market?
According to our research, the market is growing owing to rising joint disorder burden and increasing demand for non-surgical treatment options. Several key drivers exist for the growth of the osteoarthritis injectable sector. They include:
- Osteoarthritis Case Growth: Rising knee and hip osteoarthritis cases are increasing treatment demand.
- Growing Elderly Population: Increase in the number of elderly patients increases treatment volumes.
- Regenerative Treatment Development: Growing interest in platelet-rich plasma and biological advances.
This aligns with the rising focus on mobility improvement, pain reduction, and early joint care.
Request a free sample copy or read the full market insights: Osteoarthritis Injectable Market Report
Which Key Segments are Driving Osteoarthritis Injectable Market?
By Injectable Type Analysis
Hyaluronic acid injections segment held the largest market share due to strong demand for joint lubrication and pain relief.
By Anatomy Analysis
Knee osteoarthritis segment dominated the market due to high global prevalence and rising obesity-linked joint stress.
By End User Analysis
Hospital pharmacies segment dominated the market due to strong physician-led treatment administration and higher patient volume.
Which is Dominating Region in Osteoarthritis Injectable Market?
North America: North America dominated the industry in 2025 due to strong healthcare spending and advanced orthopedic treatment access.
Asia Pacific: Asia Pacific is expected to grow at the fastest rate due to rising elderly population and improving orthopedic care in China and India.
Where is Osteoarthritis Injectable Market Headed?
According to analysis, the market is moving toward steady expansion supported by regenerative therapy innovation, outpatient care growth, and wider adoption of image-guided joint injections.
What Osteoarthritis Injectable Market Report Reveals?
- What is the global market size, growth trend, and CAGR for osteoarthritis injectable through 2034?
- What are the factors driving the market growth?
- Which companies make up the top players, and how do they compare in competitive positioning?
- How are companies reducing biologic injection costs to improve adoption in emerging markets?
- How are regenerative therapies changing competition in the global osteoarthritis injectables industry?
- What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- Where do new opportunities arise in the osteoarthritis injectable market?
Who are Major Osteoarthritis Injectable Market Contributors?
According to our study, a few firms are leading in the global market. The following are some of the major market contributors:
- Anika Therapeutics, Inc.
- Bioventus Inc.
- Biosplice Therapeutics, Inc.
- Ferring Pharmaceuticals A/S
- Fidia Farmaceutici S.p.A.
- Globus Medical, Inc.
- Merck KGaA
- Novartis AG
- Pacira BioSciences, Inc.
- Paradigm Biopharmaceuticals Ltd.
- Sanofi S.A.
- Smith & Nephew plc
Market Segments Covered
By Injectable Type Outlook (Revenue, USD Billion, 2021-2034)
- Hyaluronic Acid Injections
- Corticosteroid Injections
- Platelet-rich Plasma (PRP) Injections
- Placental Tissue Matrix (PTM) Injections
- Acetylsalicylic Acid (ASA) Injections
- Others
By Anatomy Outlook (Revenue, USD Billion, 2021-2034)
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Others
By End User Outlook (Revenue, USD Billion, 2021-2034)
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Regional Outlook (Revenue, USD Billion, 2021-2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
